Targeting stem cells: The path to curing poor-prognosis leukaemia

Researchers at Children's Cancer Institute have discovered what could prove a new and improved way to treat the poor-prognosis blood cancer, acute myeloid leukaemia or AML.

Read more: https://www.eurekalert.org/pub_releases/2020-06/ccia-tsc061820.php